Contact: John Lewis
(O) 202.464.9340
(M) 202.285.5726
ACRO Executive Director Doug Peddicord Moderating Panel
On HIPAA and Comparative Effectiveness Research at DIA
June 14, 2011 – WASHINGTON, D.C. – Douglas Peddicord, Ph.D., Executive Director of the Association of Clinical Research Organizations will be moderating a session at the 2011 Drug Information Association Annual Meeting titled : “Encouraging Comparative Effectiveness Research While Protecting Privacy: Can We Develop a Research Safe Harbor for CER?”
The session will be held Wednesday, June 22 at 3:30 p.m. during the DIA Annual Meeting in Chicago. Panelists include: Dr. Felix Khin Maung-Gyi, founder and CEO of Chesapeake Research Review, Inc, an independent IRB; Tina Grande; senior vice president of policy at the Healthcare Leadership Council; and Ann Waldo, partner in the law firm of Wittie, Letsche, and Waldo, LLP.
“Many health researchers contend that HIPAA and the Common Rule unnecessarily restrict access to data needed to facilitate CER and other types of information-based research,” said Dr. Peddicord. “This session builds on a policy framework we outlined in an article in Health Affairs that we believe would encourage CER while also protecting patient privacy. We look forward to furthering this debate at the DIA forum.”
About ACRO
The Association of Clinical Research Organizations (ACRO) represents companies whose focus is clinical research. The association provides an active voice for the global CRO industry, which provides specialized services that are integral to the discovery and development of drugs, biologics, vaccines and medical devices. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ approximately 70,000 professionals worldwide and annually conduct more than 9,000 clinical trials involving nearly 2 million participants in 115 countries. For more information, please visit www.www.acrohealth.org.